XRAY · DENTSPLY SIRONA Inc.

Back to holdings

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering.

Close · 3M

-0.30%

Held by 0 AI ETFs

None of the tracked AI ETFs currently hold this name.

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals8

Win rate100% (8/8)

Avg buy return+23.29%

AIVLno longer held17 signals

AIVL · Exit · 1d

WisdomTree's AIVL ETF, which differentiates genuine value from value traps within a universe of US value stocks, eliminated DENTSPLY SIRONA (XRAY) from its approximately 100-stock portfolio on July 2, 2026. This removal occurred during the fund's periodic rebalancing, where the AI re-evaluates holdings based on fundamental metrics like margins, return on capital, and debt, alongside valuation factors such as P/E and FCF yield. Despite XRAY’s recent 30-day return of +18.4%, the AI likely determined the stock, currently trading at $11.65, no longer satisfied its specific value criteria, particularly given its longer-term 1-year return of -24.2%. The AI’s analysis likely concluded that XRAY’s financial profile or valuation at this price point did not represent a true value opportunity.

weight 0.218% → 0 (exited)·stock up 18.5% in the 30 days before

Jul 2·entry $11.65·now $13.40

+15.02%

since Jul 2

AIVL · Accumulation · 5d

XRAY trades at $11.09, representing a 28.0% decline over the past year and placing it at 66% of its 52-week high. This makes DENTSPLY SIRONA a candidate for AIVL's pre-filtered US value-factor pool, where its AI then evaluates fundamentals like margins and return on capital, alongside valuation metrics such as P/E or FCF yield, to distinguish genuine value from potential traps. Between late June and early July, the fund gradually increased its allocation to XRAY from 0.1999% to 0.2180% of its portfolio, coinciding with the stock's recent 13.9% 30-day return after earlier 90-day and one-year declines. This pattern suggests AIVL's AI perceives the current price level and recent stabilization as an indicator of underlying value rather than a transient rebound.

weight 0.205% → 0.218% (+0.013 pp)·stock up 10.7% in the 30 days before

Jul 1·entry $11.09·now $13.40Chased

+20.83%

since Jul 1

AIVL · Accumulation · 5d

AIVL's AI, designed to distinguish genuine value from value traps within a universe of around 100 US value stocks, is exhibiting a measured accumulation of DENTSPLY SIRONA (XRAY). This gradual increase in weighting, moving from 0.2008% to 0.2153% over several trading days, is consistent with the ETF's periodic rebalancing approach rather than frequent, opportunistic trading. The AI’s analysis likely concludes that XRAY, currently priced at $10.82 and 64% below its 52-week high, represents a compelling value opportunity. The fund's model, using fundamentals like margins and return on capital along with valuation metrics such as P/E and FCF yield, presumably sees underlying strength that mitigates concerns from the stock’s substantial 32.1% decline over the past year.

weight 0.201% → 0.215% (+0.015 pp)·stock up 10.1% in the 30 days before

Jun 26·entry $11.01·now $13.40Chased

+21.71%

since Jun 26

AIVL · Weight increase · 3d

DENTSPLY SIRONA (XRAY) currently trades at $11.01, positioning it at 65% of its 52-week high of $16.85, near the lower end of its $9.64 to $16.85 range. After a significant 29.6% decline over the past year and an 11.8% drop in the last 90 days, the recent 5.8% return over the past 30 days suggests a potential stabilization or early reversal from a deeply discounted position. This confluence of a depressed valuation following a prolonged downturn, coupled with recent upward momentum, aligns with AIVL's AI-driven strategy to identify genuine value within its pre-filtered US value-factor pool. The AI, assessing fundamentals like margins, return on capital, and debt alongside valuation metrics such as P/E, P/B, and FCF yield, increased XRAY's weight consecutively from 0.2030% on June 23rd to 0.2104% on June 25th, indicating its algorithm found compelling value at this price point, distinguishing it from a 'value trap' within the Health Care sector. This periodic adjustment by WisdomTree’s AI suggests its models are favoring XRAY as a name with underlying financial merit at its current price.

weight 0.200% → 0.210% (+0.011 pp)·stock up 7.9% in the 30 days before

Jun 25·entry $10.78·now $13.40Chased

+24.30%

since Jun 25

AIVL · Weight increase · 2d

The detected pattern in AIVL for DENTSPLY SIRONA (XRAY) reveals a recent sequence of increasing weight, moving from 0.1999% to 0.2085% over the last several recorded days. This nuanced, upward adjustment of allocation makes sense for AIVL's strategy, which employs AI to distinguish true value within its pre-filtered US value-factor pool. Given XRAY's current price of $10.52, residing at 62% of its 52-week high and experiencing a 34.7% decline over the past year, the AI-driven methodology likely identifies DENTSPLY SIRONA as a potential value opportunity. The fund's AI, which considers fundamentals like margins and return on capital alongside valuation metrics such as P/E and free cash flow yield, appears to be interpreting the stock's recent price depreciation as a signal of undervaluation rather than a fundamental flaw, leading to these measured portfolio increases.

weight 0.200% → 0.208% (+0.009 pp)·stock up 3.0% in the 30 days before

Jun 24·entry $10.52·now $13.40Chased

+27.38%

since Jun 24

AIVL · Weight decrease · 2d

The weight of DENTSPLY SIRONA (XRAY) in AIVL exhibits a gradual, incremental decrease, notably falling from 0.2062% on June 16th to 0.1999% by June 22nd. This subtle, multi-basis-point scaling back occurs as XRAY trades at $10.15, near its 52-week low of $9.64, following a -37.4% one-year return. Within AIVL's mandate to distinguish genuine value from value traps using fundamentals like margins and debt alongside valuation metrics, this sustained price erosion likely triggers the AI to reassess XRAY's underlying financial health. The AI's continuous scoring and periodic rebalance process would interpret such a deep, prolonged decline in a US value stock as a potential red flag, leading to the measured reduction of exposure as it flags increasing risk of a value trap rather than a deeper bargain.

weight 0.206% → 0.200% (-0.006 pp)·stock up 3.2% in the 30 days before

Jun 22·entry $10.15·now $13.40

+32.02%

since Jun 22

AIVL · Weight decrease · 3d

WisdomTree’s AIVL fund employs AI to identify genuine value opportunities and avoid value traps among its approximately 100 US value stocks. The consecutive weight decrease in XRAY, particularly from June 10th to 12th, suggests the AI's assessment of fundamentals and valuation metrics has flagged the stock as a potential value trap. Despite XRAY trading near its 52-week low at $10.14, its consistent underperformance, including a -9.5% 30-day return, likely triggered a lower score based on the AI's analysis of margins, return on capital, or free cash flow yield. The fund's periodic rebalancing mechanism is reflecting this AI-driven re-evaluation, moving XRAY further down its priority list within the value universe.

weight 0.210% → 0.201% (-0.009 pp)·stock down 3.4% in the 30 days before

Jun 12·entry $10.09·now $13.40

+32.80%

since Jun 12

AIVL · Weight decrease · 2d

AIVL’s AI, tasked with identifying genuine value amidst potential traps, registered a pattern of declining allocation to DENTSPLY SIRONA Inc., including consecutive weight decreases. This measured reduction occurs as XRAY trades at $10.14, very close to its 52-week low of $9.64, and after suffering a 1-year return of -36.5%. Such sustained negative price action across 30, 90, and 365 days likely triggers AIVL’s algorithm to scrutinize the Health Care company’s fundamental strength, evaluating metrics like margins, return on capital, and debt against its valuation. The periodic adjustments, seen in changes from 0.2109% to 0.2038% over the period, indicate the AI is prudently reassessing XRAY's position within the fund's US value-factor universe, potentially flagging it as a situation warranting reduced exposure rather than an undervalued asset.

weight 0.210% → 0.204% (-0.006 pp)·stock down 7.8% in the 30 days before

Jun 11·entry $10.14·now $13.40

+32.15%

since Jun 11

AIVL · Weight increase · 3d

The weight change for DENTSPLY SIRONA in AIVL initially showed a gradual decline through late May and early June, then shifted to a series of slight daily increases from June 4th to June 8th, moving from 0.1953% to 0.2098%. This upward adjustment in allocation for XRAY occurs as its price has significantly declined, experiencing a -36.6% one-year return and trading near its 52-week low at $10.47. Given AIVL's strategy to use AI to discern genuine value from potential value traps within a US value-factor universe, these consecutive increases suggest the AI has re-evaluated XRAY's fundamentals and valuation metrics (P/E, P/B, FCF yield) at a lower price point, concluding it now presents a compelling value opportunity. The AI's continuous reassessment, even if rebalancing is periodic, appears to have triggered a renewed conviction in the Health Care company as a mispriced asset, causing its allocation to trend upward within the portfolio.

weight 0.195% → 0.210% (+0.015 pp)·stock down 6.4% in the 30 days before

Jun 8·entry $10.26·now $13.40Chased

+30.60%

since Jun 8

AIVL · Weight increase · 2d

weight 0.195% → 0.205% (+0.010 pp)·stock down 10.2% in the 30 days before

Jun 5·entry $10.00·now $13.40Chased

+34.00%

since Jun 5

AIVL · Weight decrease · 5d

weight 0.227% → 0.195% (-0.031 pp)·stock down 13.9% in the 30 days before

Jun 3·entry $9.64·now $13.40

+39.00%

since Jun 3

AIVL · Weight decrease · 4d

DENTSPLY SIRONA shares currently trade at $9.83, just above their 52-week low of $9.74, reflecting significant declines of 20.1% over the last 30 days and 41.2% annually. WisdomTree’s AIVL screens for US value stocks and then employs AI to assess fundamentals like margins, return on capital, debt, and valuation metrics such as P/E, P/B, and FCF yield, specifically to identify genuine value versus potential value traps. Despite the stock entering what might appear as deep value territory, the AI's consecutive weight reductions in XRAY, from 0.2274% on May 7th to 0.2038% by June 1st, suggest its models detected a deterioration in underlying financial health or a lack of sufficient fundamental strength. This pattern indicates the AI likely flagged DENTSPLY SIRONA as a potential value trap rather than a buying opportunity, given its mandate to distinguish true value using a combination of financial metrics over simply price-based metrics. The sustained decrease, occurring over multiple rebalancing periods within May and early June, points to a persistent negative signal from the AI’s evaluation of XRAY’s core business attributes.

weight 0.227% → 0.204% (-0.023 pp)·stock down 14.7% in the 30 days before

Jun 1·entry $10.02·now $13.40

+33.73%

since Jun 1

AIVL · Weight decrease · 3d

The AI-managed AIVL, designed to differentiate genuine value from value traps based on fundamental and valuation metrics, consistently reduced its allocation to XRAY from May 13th to May 15th, reaching 0.2109%. This specific adjustment occurred while DENTSPLY SIRONA traded around its current $10.47 price point, following sustained 30-day and 90-day returns of -16.3% and -17.8%, respectively. The repeated decrease suggests AIVL's AI likely flagged the health care equipment manufacturer as a potential value trap, despite its price being near 62% of its 52-week high, possibly due to concerns over deteriorating margins, return on capital, or increasing debt. This move indicates the AI's algorithm, during a periodic reassessment, found the underlying fundamentals insufficient to warrant a higher weighting, even as the stock approached its $9.74 52-week low.

weight 0.227% → 0.211% (-0.016 pp)·stock down 16.7% in the 30 days before

May 15·entry $10.07·now $13.40

+33.07%

since May 15

AIVL · Weight decrease · 2d

The AI ETF likely initiated a consecutive weight decrease for XRAY after its algorithms identified accumulating negative signals, possibly related to deteriorating company fundamentals or sector-specific headwinds in healthcare. This sustained divestment suggests the AI perceives a persistent negative outlook for the stock. For retail investors, such a consistent algorithmic reduction should prompt a thorough re-evaluation of their own XRAY holdings and a deeper dive into the company's prospects, recognizing the AI's advanced analytical capabilities.

weight 0.227% → 0.214% (-0.012 pp)·stock down 13.6% in the 30 days before

May 14·entry $10.41·now $13.40

+28.72%

since May 14

AIVL · Weight decrease · 2d

The AI ETF likely detected deteriorating fundamental metrics or negative technical indicators for DENTSPLY SIRONA, such as slowing growth or increased competitive pressures within the healthcare sector, prompting a consecutive reduction in its portfolio weight. For retail investors, this consistent de-weighting pattern by an AI fund should serve as a strong signal to conduct thorough independent research on XRAY's recent performance and news, re-evaluating their own investment thesis before making any investment decisions.

weight 0.236% → 0.227% (-0.008 pp)·stock down 8.6% in the 30 days before

May 7·entry $10.96·now $13.40

+22.26%

since May 7

AIVL · Weight increase · 2d

The AI ETF's consecutive weight increase in XRAY, initiated from zero, suggests its algorithms have identified new positive fundamental or technical signals for DENTSPLY SIRONA. This likely reflects an emerging positive outlook for the healthcare company, potentially driven by sector trends, new product developments, or a favorable re-evaluation of its valuation. For retail investors, this pattern indicates that sophisticated AI models are detecting potential upside, making XRAY a candidate for further personal research into its underlying business drivers and recent news.

weight 0 → 0.246% (new)·stock up 1.3% in the 30 days before

May 1·entry $11.81·now $13.40Chased

+13.46%

since May 1

AIVL · New entry · 1d

The AI ETF likely added XRAY because its sophisticated algorithms detected an emerging positive signal, potentially related to improved financial outlook, favorable industry trends in medical devices, or attractive valuation metrics that met its inclusion thresholds. For a retail investor, this new entry highlights how AI can quickly act on detected opportunities, serving as a prompt to conduct independent due diligence into XRAY's recent performance and sector catalysts.

weight 0 → 0.244% (new)·stock up 1.3% in the 30 days before

Apr 30·entry $11.75·now $13.40Chased

+14.04%

since Apr 30

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.